Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard M Gebel

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Clinical Transplantation|February 10, 2017
De novo DQ donor-specific antibodies are associated with worse outcomes compared to non-DQ de novo donor-specific antibodies following heart transplantationRobert Townsend Cole, Jonathan Gandhi, Robert A Bray, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 5, 2017
Racial differences in the development of de-novo donor-specific antibodies and treated antibody-mediated rejection after heart transplantationRobert Townsend Cole, Jonathan Gandhi, Robert A Bray, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 28, 2019
The impact of belatacept on third-party HLA alloantibodies in highly sensitized kidney transplant recipientsRonald F Parsons, Arslan Zahid, Shalini Bumb, et al.
Journal of the American Society of Nephrology : JASN|October 2, 2021
Delayed Kinetics of IgG, but Not IgA, Antispike Antibodies in Transplant Recipients following SARS-CoV-2 InfectionPaolo Cravedi, Patrick Ahearn, Lin Wang, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 25, 2023
Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting ReportAnat R Tambur, Oriol Bestard, Patricia Campbell, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 17, 2023
Corrigendum to 'Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting Report' [American Journal of Transplantation 23 (2023) 133-149]Anat R Tambur, Oriol Bestard, Patricia Campbell, et al.
Human Immunology|March 3, 2023
COVID-19 infection and vaccination rarely impact HLA antibody profile in waitlisted renal transplant candidates- a multicenter cohortGarrett R Roll, Robert A Bray, Matthew Cooper, et al.
Transplantation|November 14, 2015
APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American DonorsBarry I Freedman, Stephen O Pastan, Ajay K Israni, et al.
Transplantation|December 15, 2012
Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantationBrian D Tait, Caner Süsal, Howard M Gebel, et al.
Gastroenterology|August 26, 2018
Evidence of Chronic Allograft Injury in Liver Biopsies From Long-term Pediatric Recipients of Liver TransplantsSandy Feng, John C Bucuvalas, Anthony J Demetris, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Clinical Transplantation|February 10, 2017
De novo DQ donor-specific antibodies are associated with worse outcomes compared to non-DQ de novo donor-specific antibodies following heart transplantationRobert Townsend Cole, Jonathan Gandhi, Robert A Bray, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 5, 2017
Racial differences in the development of de-novo donor-specific antibodies and treated antibody-mediated rejection after heart transplantationRobert Townsend Cole, Jonathan Gandhi, Robert A Bray, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 28, 2019
The impact of belatacept on third-party HLA alloantibodies in highly sensitized kidney transplant recipientsRonald F Parsons, Arslan Zahid, Shalini Bumb, et al.
Journal of the American Society of Nephrology : JASN|October 2, 2021
Delayed Kinetics of IgG, but Not IgA, Antispike Antibodies in Transplant Recipients following SARS-CoV-2 InfectionPaolo Cravedi, Patrick Ahearn, Lin Wang, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 25, 2023
Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting ReportAnat R Tambur, Oriol Bestard, Patricia Campbell, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 17, 2023
Corrigendum to 'Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting Report' [American Journal of Transplantation 23 (2023) 133-149]Anat R Tambur, Oriol Bestard, Patricia Campbell, et al.
Human Immunology|March 3, 2023
COVID-19 infection and vaccination rarely impact HLA antibody profile in waitlisted renal transplant candidates- a multicenter cohortGarrett R Roll, Robert A Bray, Matthew Cooper, et al.
Transplantation|November 14, 2015
APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American DonorsBarry I Freedman, Stephen O Pastan, Ajay K Israni, et al.
Transplantation|December 15, 2012
Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantationBrian D Tait, Caner Süsal, Howard M Gebel, et al.
Gastroenterology|August 26, 2018
Evidence of Chronic Allograft Injury in Liver Biopsies From Long-term Pediatric Recipients of Liver TransplantsSandy Feng, John C Bucuvalas, Anthony J Demetris, et al.
Pageof 9